Cancer Drugs
Padcev
Also known as: Enfortumab vedotin, Anti–Nectin-4 ADC
Definition
Enfortumab vedotin, an antibody-drug conjugate targeting Nectin-4 for advanced urothelial carcinoma.
Detailed Explanation
Padcev delivers a vedotin payload to Nectin-4–expressing bladder cancer cells and is used after prior platinum and immunotherapy.